Flume Patrick A, Strange Charlie, Ye Xiaobu, Ebeling Myla, Hulsey Thomas, Clark Leslie L
Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas St, 812-CSB, Charleston, SC 29425, USA.
Chest. 2005 Aug;128(2):720-8. doi: 10.1378/chest.128.2.720.
Spontaneous pneumothorax is a complication that is commonly reported in patients with cystic fibrosis (CF). An understanding of the pathophysiology of this complication and its consequences is important for the management of patients with CF.
To identify risk factors associated with pneumothorax and to determine the prognosis of CF patients following an episode of pneumothorax.
A retrospective observational cohort study of the National Cystic Fibrosis Patient Registry between the years 1990 and 1999.
The registry contained data on 28,858 patients with CF who had been followed up over those 10 years at CF centers across the United States.
Pneumothorax occurred with an average annual incidence of 0.64% and in 3.4% of patients overall. There was no increased occurrence by sex, but CF was more prevalent in older patients (mean [+/- SD] age, 21.9 +/- 9.1 years) with more severe pulmonary impairment (nearly 75% of patients with FEV1 of < 40% predicted). The principal risks associated with an increased occurrence of pneumothorax included the presence of Pseudomonas aeruginosa (odds ratio [OR], 2.3), Burkholderia cepacia (OR, 1.8), or Aspergillus (OR, 1.3) in sputum cultures, FEV1 < 30% predicted (OR, 1.5), enteral feeding (OR, 1.7), Medicaid insurance (OR, 1.1), pancreatic insufficiency (OR, 1.4), allergic bronchopulmonary aspergillosis (OR, 1.5), and massive hemoptysis (OR, 1.4). There is an increased morbidity (eg, increased number of hospitalizations and number of days spent in the hospital) and an increased 2-year mortality rate following pneumothorax.
Pneumothorax is a serious complication in CF patients, occurring more commonly in older patients with more advanced lung disease. Nearly 1 in 167 patients will experience this complication each year. There is an attributable mortality to the complication and considerable morbidity, resulting in increased health-care utilization and a measurable decline in lung function.
自发性气胸是囊性纤维化(CF)患者中常见的一种并发症。了解该并发症的病理生理学及其后果对于CF患者的管理至关重要。
确定与气胸相关的危险因素,并确定CF患者气胸发作后的预后。
对1990年至1999年期间国家囊性纤维化患者登记处进行的一项回顾性观察队列研究。
该登记处包含了在美国各地CF中心对28858例CF患者进行的10年随访数据。
气胸的平均年发病率为0.64%,总体患者中的发生率为3.4%。气胸发生率在性别上没有增加,但在年龄较大(平均[±标准差]年龄为21.9±9.1岁)、肺部损害更严重(近75%的患者FEV1<预测值的40%)的患者中CF更为普遍。与气胸发生率增加相关的主要风险包括痰培养中存在铜绿假单胞菌(比值比[OR],2.3)、洋葱伯克霍尔德菌(OR,1.8)或曲霉菌(OR,1.3),FEV1<预测值的30%(OR,1.5),肠内喂养(OR,1.7),医疗补助保险(OR,1.1),胰腺功能不全(OR,1.4),变应性支气管肺曲霉菌病(OR,1.5)和大量咯血(OR,1.4)。气胸后发病率增加(如住院次数增加和住院天数增加),2年死亡率也增加。
气胸是CF患者的一种严重并发症,在肺部疾病更严重的老年患者中更常见。每年每167名患者中就有近1人会发生这种并发症。该并发症存在可归因的死亡率和相当高的发病率,导致医疗保健利用率增加,肺功能出现可测量的下降。